Novoprotein Scientific Balance Sheet Health
Financial Health criteria checks 5/6
Novoprotein Scientific has a total shareholder equity of CN¥2.2B and total debt of CN¥17.9M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are CN¥2.3B and CN¥121.1M respectively.
Key information
0.8%
Debt to equity ratio
CN¥17.87m
Debt
Interest coverage ratio | n/a |
Cash | CN¥1.39b |
Equity | CN¥2.19b |
Total liabilities | CN¥121.06m |
Total assets | CN¥2.31b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688137's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥57.4M).
Long Term Liabilities: 688137's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥63.7M).
Debt to Equity History and Analysis
Debt Level: 688137 has more cash than its total debt.
Reducing Debt: 688137 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: 688137's debt is well covered by operating cash flow (296.4%).
Interest Coverage: Insufficient data to determine if 688137's interest payments on its debt are well covered by EBIT.